mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.005 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.006 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.009 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.01 |